Participants
Contact
Miquel Duran, chemist and IRB Barcelona researcher in the Structural Bioinformatics and Network Biology Group, talks to Onda Regional de Murcia about his research into the side-effects of drugs. The study published in Chemistry and Biology (Cell), explains Duran, "will be allow the pharmaceutical industry to improve the next generation of drugs". Duran goes on to say that they are aware that multinational pharmaceutical companies are interested in the study and that the research may also be useful for physicians".
"It is very difficult to predict the effects that a drug can have in a small percentage of people, but this study and others are showing the direction to take", said Duran during the extensive interview for the programme "Adelantos".
Listen to the interview in Adelantos (ORM)
Link to the programme website
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
